Suppr超能文献

不同肌层浸润性膀胱癌治疗方法后健康相关生活质量概述:伞式综述。

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review.

机构信息

Department of Human Structure and Repair, Ghent University, Corneel Heymanslaan 10, 9000, Ghent, Belgium.

Department of Public Health and Primary Care, University Hospital, Ghent University, Ghent, Belgium.

出版信息

Qual Life Res. 2020 Nov;29(11):2887-2910. doi: 10.1007/s11136-020-02544-z. Epub 2020 Jun 6.

Abstract

PURPOSE

This umbrella review aims to evaluate the quality, summarize and compare the conclusions of systematic reviews investigating the impact of curative treatment options on health-related quality of life (HRQoL) in muscle-invasive bladder cancer (MIBC).

METHODS

The Cochrane Library, MEDLINE, Embase and Web of Science were searched independently by two authors from inception until 06 January 2020. Systematic reviews and meta-analyses assessing the impact of any curative treatment option on HRQol in MIBC patients were eligible. Risk of bias was assessed using the AMSTAR 2 tool.

RESULTS

Thirty-two reviews were included. Robot-assisted RC with extracorporeal urinary diversion and open RC have similar HRQoL (n = 10). Evidence for pelvic organ-sparing RC was too limited (n = 2). Patients with a neobladder showed better overall and physical HRQoL outcomes, but worse urinary function in comparison with ileal conduit (n = 17). Bladder-preserving radiochemotherapy showed slightly better urinary and sexual but worse gastro-intestinal HRQoL outcomes in comparison with RC patients (n = 6). Quality of the reviews was low in more than 50% of the available reviews and most of the studies included in the reviews were nonrandomized studies.

CONCLUSION

This umbrella review gives a comprehensive overview of the available evidence to date.

摘要

目的

本系统评价旨在评估质量,总结和比较系统评价的结论,这些系统评价研究了治愈性治疗方案对肌层浸润性膀胱癌(MIBC)患者健康相关生活质量(HRQoL)的影响。

方法

两位作者独立检索 Cochrane 图书馆、MEDLINE、Embase 和 Web of Science,检索时间从建库开始至 2020 年 1 月 6 日。评估任何治愈性治疗方案对 MIBC 患者 HRQol 影响的系统评价和荟萃分析符合纳入标准。使用 AMSTAR 2 工具评估偏倚风险。

结果

共纳入 32 项综述。机器人辅助 RC 伴体外尿流改道和开放 RC 的 HRQoL 相似(n=10)。保留盆腔器官的 RC 的证据有限(n=2)。与回肠导管相比,新膀胱患者的整体和生理 HRQoL 结局更好,但尿功能更差(n=17)。与 RC 患者相比,膀胱保留放化疗在尿和性功能方面稍好,但胃肠 HRQoL 更差(n=6)。超过 50%的可用综述质量较低,且综述中纳入的大多数研究是非随机研究。

结论

本系统评价全面概述了迄今为止的现有证据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验